Back to Search
KEITH GOTTESDIENER, M.D.
M.D.
Infectious Disease Physician
NPI: 1821150376Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
52203(MA)
Research & Publications (20)
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
PMID 12209041·Rheumatology (Oxford)·2002
3-trial
Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.
PMID 19004846·J Clin Pharmacol·2009
2-rct
Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.
PMID 19433563·Antimicrob Agents Chemother·2009
3-trial
A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
PMID 19602719·J Clin Pharmacol·2009
4-observational
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.
PMID 19491335·J Clin Pharmacol·2009
4-observational
Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies.
PMID 19421185·Clin Pharmacol Ther·2009
3-trial
The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants.
PMID 19443681·J Clin Pharmacol·2009
4-observational
Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse event.
PMID 19199043·AAPS J·2009
7-preclinical
Effect of tipranavir-ritonavir on pharmacokinetics of raltegravir.
PMID 19398643·Antimicrob Agents Chemother·2009
3-trial
Lack of a significant drug interaction between raltegravir and tenofovir.
PMID 18625763·Antimicrob Agents Chemother·2008
2-rct
Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
PMID 18756184·Pediatr Infect Dis J·2008
4-observational
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir.
PMID 18838589·Antimicrob Agents Chemother·2008
2-rct
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
PMID 18353996·J Clin Pharmacol·2008
2-rct
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
PMID 18580870·Clin Pharmacol Ther·2008
2-rct
Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects.
PMID 18503607·Br J Clin Pharmacol·2008
2-rct
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers.
PMID 18508950·J Clin Pharmacol·2008
2-rct
Atazanavir modestly increases plasma levels of raltegravir in healthy subjects.
PMID 18513146·Clin Infect Dis·2008
2-rct
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
PMID 18441333·J Clin Pharmacol·2008
4-observational
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
PMID 19012954·Lancet·2008
3-trial
The effect of moxifloxacin on QTc and implications for the design of thorough QT studies.
PMID 19238652·Clin Pharmacol Ther·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MRL-126 EAST LINCOLN AVE.
RAHWAY, NJ 07065 - Phone
- (732) 594-4217
Quick Facts
- NPI
- 1821150376
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile